News Summary

China has become the first country to approve a commercially available brain chip to aid individuals with disabilities. Developed by Neuracle Medical Technology, the NEO implant translates thoughts into movements for people with paralysis, enabling them to control an assistive robotic hand. The chip, implanted in the skull with electrodes placed on the brain, allows users to perform basic tasks through thought. After successful safety testing, China’s National Medical Products Administration authorized its use for those aged 19 to 60 with paralysis from neck or spinal cord injuries. This approval highlights China’s strategic move to dominate the brain-computer interface (BCI) industry, as outlined in a recent policy document aiming to establish a globally competitive BCI sector within five years. The document encourages the mass production of non-invasive devices for various applications, including high-risk industries. The NEO’s approval marks a significant advancement in restoring autonomy to people with disabilities, incorporating technology that allows communication through thoughts and operation of computers without physical movement.